Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interferon omega (IFN-ω) is a type I interferon cytokine involved in immune regulation and antiviral defense. It binds to the IFNAR receptor complex and activates the JAK/STAT signaling pathway, leading to antiviral, antiproliferative, and immunomodulatory effects. It has veterinary applications for treating viral infections in animals but remains investigational for human use.
Binds to the type I interferon receptor (IFNAR) complex, activating the JAK/STAT signaling pathway.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interferon omega (IFN-ω).